Holen Sie sich die Stockscreener-App
1.96
0.00%
0.00
Handel nachbörslich:
1.96
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
What is the earnings history of Gossamer Bio Inc.Global Markets & Fast Gaining Stock Reports - classian.co.kr
Analysts' Revenue Estimates For Gossamer Bio, Inc. (NASDAQ:GOSS) Are Surging Higher - Yahoo Finance
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates - MSN
Gossamer Bio shares rise 1.52% after-hours following XOMA Royalty's acquisitions and pipeline advancements. - AInvest
Gossamer Bio Reports Q2 2025 Financial Results - TipRanks
Analyzing recovery setups for Gossamer Bio Inc. investorsAI-Powered Stock Trend Movement Analysis - Newser
What machine learning models say about Gossamer Bio Inc.Free Technical Entry Strategy for Beginners - Newser
Will Gossamer Bio Inc. see short term momentumStock Portfolio Risk and Return Analysis - Newser
Is Gossamer Bio Inc. stock poised for growthGrowth Watchlist for Long Term Positioning - Newser
Multi asset correlation models including Gossamer Bio Inc.Machine Learning Intraday Signal Forecast - Newser
Institutional investors in Gossamer Bio, Inc. (NASDAQ:GOSS) see US$54m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Is Gossamer Bio Inc. trending in predictive chart modelsOversold Stock Bounce Playbook Generator - Newser
What makes Gossamer Bio Inc. stock price move sharplyReal-Time Investment Signal Forecast with AI - Newser
Real time scanner hits for Gossamer Bio Inc. explainedMarket Timing Strategy with Technical Filters - Newser
H.C. Wainwright Maintains Gossamer Bio(GOSS.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 7, 2025 - BioSpace
Gossamer Bio earnings beat by $0.01, revenue topped estimates - Investing.com Australia
Gossamer Bio Reports Q2 2025 Financials, Announces PROSERA Phase 3 Topline Results Expected in February 2026, and First Site Activations for Registrational Phase 3 SERANATA Study in PH-ILD Expected in Q4 2025. - AInvest
Gossamer Bio 2025 Q2 Earnings Sharp Net Loss Amid Revenue Drop - AInvest
Gossamer Bio 2025 Q2 Earnings Sharp Net Income Decline of 177.7% - AInvest
Gossamer Bio shares fall 7.41% premarket despite beating earnings expectations. - AInvest
Gossamer Bio Inc. Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Gossamer Bio: Q2 Earnings Snapshot - New Haven Register
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
How Gossamer Bio Inc. stock performs during market volatilityBuy and Exit Strategy Based on Momentum - Newser
Gossamer Bio shares rise 1.39% after-hours despite Q2 revenue drop of 88%. - AInvest
GOSS Achieves Strong Q2 Revenue and Prepares for Commercial Expa - GuruFocus
Gossamer Bio Reports Q2 Revenue Drop of 88% - AInvest
Gossamer Bio Q2 revenue drops 88% - MarketScreener
Gossamer Bio's 390-Patient PAH Trial Nears Crucial February Readout, $213M Cash Runway - Stock Titan
Will Gossamer Bio Inc. price bounce be sustainableFree Smart Trade Plans With Risk Protection - Newser
Can Gossamer Bio Inc. rally from current levelsStrategy Builder for Growth Focused Traders - Newser
Why is Gossamer Bio Inc. stock attracting strong analyst attentionExponentially increasing returns - Jammu Links News
Custom strategy builders for tracking Gossamer Bio Inc.Market Liquidity and Price Flow Analysis - Newser
Published on: 2025-08-04 06:30:01 - beatles.ru
Is Gossamer Bio Inc. forming a reversal patternReal-Time Investment Signal Forecast with AI - Newser
How volatile is Gossamer Bio Inc. stock compared to the marketCapitalize on market momentum for maximum gains - Jammu Links News
Why Gossamer Bio Inc. is moving todayStock Market Watch with Smart Filters - Newser
Why Gossamer Bio Inc. stock attracts strong analyst attentionLong-Term Allocation Strategy Summary Breakdown - Newser
What are the latest earnings results for Gossamer Bio Inc.Capitalize on fast-moving stock trends - Jammu Links News
What is the dividend policy of Gossamer Bio Inc. stockCapitalize on high-yield stocks early - Jammu Links News
When is Gossamer Bio Inc. stock expected to show significant growthFree Expert Stock Watchlist - Jammu Links News
How strong is Gossamer Bio Inc. company’s balance sheetUnlock daily trading alerts for profits - Jammu Links News
Is it the right time to buy Gossamer Bio Inc. stockCapitalize on stocks with high profit margins - Jammu Links News
How does Gossamer Bio Inc. compare to its industry peersInvest smarter with real-time trading alerts - Jammu Links News
Does Gossamer Bio Inc. stock perform well during market downturnsAchieve breakthrough profits with smart strategies - Jammu Links News
Gossamer Bio Inc. Stock Analysis and ForecastAmplify your gains with low-risk picks - Jammu Links News
What institutional investors are buying Gossamer Bio Inc. stockBuild a portfolio that stands the test of time - Jammu Links News
How many analysts rate Gossamer Bio Inc. as a “Buy”Discover market opportunities others miss - Jammu Links News
What catalysts could drive Gossamer Bio Inc. stock higher in 2025Double-digit growth - Jammu Links News
0.44%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):